Home
About
Overview
Sharing Data
ORCID
Help
History (18)
FRMD4A/RET: A Novel RET Oncogenic Fusion Variant in Non-Small Cell Lung Carcinoma.
Radioprotection by WR-151327 against the late normal tissue damage in mouse hind legs from gamma ray radiation.
Risk perception and surveillance uptake in individuals at increased risk for pancreatic ductal adenocarcinoma.
The 5-HT1A and 5-HT2A/2C receptor antagonists WAY-100635 and ritanserin do not attenuate D-fenfluramine-induced fos expression in the brain.
Hemispheric specialization varies with EEG brain resting states and phase of menstrual cycle.
See All 18 Pages
Find People
Find Everything
Edit My Profile
My Person List (
0
)
Return to Top
Login
Username
Password